RxDoctor Payments Data

Connie Lasley

Nurse Practitioner · Andalusia, ALNPI 1548858202

Payments from drug & device makers

$1,706in general payments, 2019–2025

Across 75 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$521
  • Dendreon Pharmaceuticals LLC$416
  • Myovant Sciences Inc.$198
  • Johnson & Johnson$136
  • Endo Pharmaceuticals Inc.$92
  • Olympus America Inc.$48
  • plus $295 from 11 others

What the payments were for

  • Food & beverage$1,38981%
  • Education$31719%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,706 in reported general payments places this provider in the 75th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama

Medicare billing

Part B allowed, 2024
$41,122
Medicare patients
258
Services billed
1,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron138$74,298
Estradiol146$11,658
Solifenacin Succinate180$7,031
Tamsulosin Hcl359$4,207
Tolterodine Tartrate ErTolterodine Tartrate42$3,325
Finasteride117$1,457
YuvafemEstradiol15$1,120
Oxybutynin Chloride49$1,073
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst46$913
Methenamine Hippurate12$687
Ciprofloxacin Hcl46$348
Cefdinir22$321
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim41$207
Sildenafil Citrate13$154
Fluconazole22$149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$521$74,298138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,505 nurse practitioner providers in Alabama.

Other nurse practitioner in Andalusia

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →